Related Experiment Videos
Platelet 3H-rauwolscine binding in patients with panic attacks
T R Norman1, N M Kimber, F K Judd
1Department of Psychiatry, University of Melbourne, Victoria, Australia.
Psychiatry Research
|September 1, 1987
Summary
This study found no significant difference in platelet alpha 2 binding between panic attack patients and controls. These findings do not support an adrenergic abnormality in panic disorder.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Panic disorder is a debilitating condition with complex neurobiological underpinnings.
- Adrenergic system dysregulation has been implicated in the pathophysiology of panic attacks.
Purpose of the Study:
- To investigate platelet alpha 2 adrenergic receptor binding in patients with panic attacks.
- To determine if abnormalities in alpha 2 receptor density or affinity are associated with panic disorder.
Main Methods:
- Platelet alpha 2 binding was quantified using the radioligand 3H-rauwolscine.
- The study included 14 patients diagnosed with panic attacks and 21 healthy controls.
- Binding parameters, including Bmax (maximum binding capacity) and Kd (dissociation constant), were analyzed.
Main Results:
- No statistically significant differences were observed in Bmax values between panic patients and controls (p > 0.05).
- A trend towards a higher Kd was noted in panic patients, but this did not reach statistical significance.
- The results suggest no significant alteration in platelet alpha 2 adrenergic receptor availability or affinity in individuals with panic attacks.
Conclusions:
- The study's findings do not provide evidence for a primary adrenergic abnormality in the platelet alpha 2 receptors of panic disorder patients.
- Further research may be needed to explore other neurobiological mechanisms contributing to panic attacks.